Loading
Loading…
Loading…
| # | Schedule | Awarded To | Bids | Value |
|---|---|---|---|---|
| 1 | Schedule 1 | Not yet disclosed by govt.Likely | 2 | - |
| 2 | Schedule 2 | EVAAN LIFESCIENCES PRIVATE LIMITEDLikely | 2 | ₹4.0 L |
| 3 | Schedule 3 | MEDIKON INDIA PRIVATE LIMITEDLikely | 1 | ₹4.9 L |
| 4 | Schedule 4 | Not yet disclosed by govt.Likely | 21 | - |
| 5 | Schedule 5 | SMPL LIFE SCIENCES PRIVATE LIMITEDLikely | 5 | ₹15,120 |
Tender Value
₹49.3 L
EMD Value
Exempted
Closing Date
19 May 2026, 6:00 pmClosed
015845_Tab Venetoclax 100 mg
011090_Peg Factor VIII 500 IU
011091_Peg Factor VIII 1000 IU
010501_Levetiracetam 100mg_ml_Vail of 5 ml inj _Old NIV_1730
011130_Esmolol 100 mg_ 10ml inj
012055_Tropicamide 1percent with 5 percent phenylephrine eye drop bott of ml
013238_ Posaconazole 40 mg_ml oral suspension bottle of 105 ml
NIV_2191_Mitomycin C 10 mg Inj
NIV_7653_Follitropin Beta 600 IU _Recombinant FSH_
016314_Abrocitinib 100mg tab
010135_Midazolam 5 mg
1ml inj
011721_Carboprost Tromethamine 250 mcq_ml 1ml inj
013907_Fosaprepitant 150 mg inj
010883_Lenalidomide 10mg capsule
011726_Mifepristone 200 mg Tab
NIV_9356_30 percent salicylic acid peel gel _60ml_
NIV_9358_Phenol 15 percent_TCA 15 percent Glycolic acid 2 percent peel
010550_phenobarbitone sod 200mg_ 1ml inj
011661_Drotaverine HCL 20mg_ml inj of 1 ml
012241_Phenobarbitone Syp 20 mg_5ml bott of 60 ml
016317_Guselkumab solution for injection 100 mg
NIV_10577_Budesonide _glycopyr onium plus formetrol fumarate dihydrate pressurized inhalaltion suspension
NIV_19_Nitazoxanide 500 mg tab
NIV_9357_Glycolic acid 33 percent_lactic acid 6percent
kojic acid peel
9171592
GEM/2026/B/7398837
Two Packet Bid
015845_Tab Venetoclax 100 mg,011090_Peg Factor VIII 500 IU,011091_Peg Factor VIII 1000 IU,010501_Le
Bengaluru Urban, Karnataka
Item wise evaluation
BOQ
9 documents required · 9 mandatory
3 yrs
₹24 L
₹98 L
10%
SAO, COMMAND HOSPITAL AIR FORCE BANGALORE, Department of Military Affairs, Indian Air Force, Ministry of, Defence, (Oic Public Fund Chafb)
Exempted
Yes
14 May 2026
4 May 2026
19 May 2026
| Item No | Item Title | Description | Qty | Unit | Consignee | Delivery (days) |
|---|---|---|---|---|---|---|
| 1 | 015845_Tab Venetoclax 100 mg | Tab Venetoclax 100 mg | 112 | NO | MedPro-03 | 60 |
| 2 | 011090_Peg Factor VIII 500 IU | Peg Factor VIII 500 IU | 60 | vial | MedPro-03 | 60 |
| 3 | 011091_Peg Factor VIII 1000 IU | Peg Factor VIII 1000 IU | 30 | vial | MedPro-03 | 60 |
| 4 | 010501_Levetiracetam 100mg_ml_Vail of 5 ml inj _Old NIV_1730 | Levetiracetam 100mg_ml_Vail of 5 ml inj | 2,400 | vial | MedPro-03 | 60 |
| 5 | 011130_Esmolol 100 mg_ 10ml inj | Esmolol 100 mg_ 10ml inj | 300 | vial | MedPro-03 | 60 |
| 6 | 012055_Tropicamide 1percent with 5 percent phenylephrine eye drop bott of ml | Tropicamide 1percent with 5 percent phenylephrine eye drop bott of ml | 1,200 | Bottle | MedPro-03 | 60 |
| 7 | 013238_ Posaconazole 40 mg_ml oral suspension bottle of 105 ml | Posaconazole 40 mg_ml oral suspension bottle of 105 ml | 60 | Bottle | MedPro-03 | 60 |
| 8 | NIV_2191_Mitomycin C 10 mg Inj | Mitomycin C 10 mg Inj | 30 | vial | MedPro-03 | 60 |
| 9 | NIV_7653_Follitropin Beta 600 IU _Recombinant FSH_ | Follitropin Beta 600 IU _Recombinant FSH | 60 | No | MedPro-03 | 60 |
| 10 | 016314_Abrocitinib 100mg tab | Abrocitinib 100mg tab | 630 | No | MedPro-03 | 60 |
Tap a document below to read it instantly. You can also download everything as a ZIP if you prefer.
bid_9171592.pdf
GEM_BID • 0.24 MB
bbqr_drugs_706_2026-03-28-10-24-30_49046ae302e81631bd7855997f0f268d.pdf
BOQ • 1.22 MB
boq_706_2026-03-28-10-24-30_2d9f1fff5d729ef45823af565ddd9015.csv
BOQ • 0.00 MB
ATC_123429c5-be6e-4703-926c1774679862161_OICMEDSTORECHAFB.pdf
GEM_OTHER • 1.25 MB
gtc.pdf
GEM_OTHER • 0.71 MB
Download all tender documents and submit your bid
Disclaimer: TenderKart has made every reasonable effort to ensure that the information on this page is accurate and authentic, however it cannot be held liable for any third-party claims or losses or any damages. TenderKart makes no warranty, expressed or implied, as to the results obtained from the use of this information. If you notice any error or omission, please let us know at .